Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465986 | PMC |
| http://dx.doi.org/10.2337/dc23-er09 | DOI Listing |
Publication Analysis
Top Keywords
erratum finerenone
4
finerenone patients
4
patients chronic
4
chronic kidney
4
kidney disease
4
disease type
4
type diabetes
4
diabetes baseline
4
baseline hba1c
4
hba1c insulin
4
Similar Publications
Author Correction: Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes.
Nat Med
December 2024
Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Correction to: Finerenone in type 2 diabetic and albuminuric renal disease patients: three case reports.
Int Urol Nephrol
December 2024
Service of Nephrology, Ospedale Regionale Di Lugano, Ospdeale Civico, Ente Ospedaliero Cantonale, Via Tesserete 46, 6903, Lugano, Switzerland.
Corrigendum to "The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges" [Metabolism 65 (2016) 1342-1349].
Metabolism
May 2018
Department of Nephrology, the Second Affiliated Hospital of Nanchang University, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!